ruboxistaurin has been researched along with glucuronyl glucosamine glycan sulfate in 3 studies
Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (glucuronyl glucosamine glycan sulfate) | Trials (glucuronyl glucosamine glycan sulfate) | Recent Studies (post-2010) (glucuronyl glucosamine glycan sulfate) |
---|---|---|---|---|---|
203 | 29 | 56 | 284 | 81 | 133 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tuttle, KR; Williams, ME | 1 |
Williams, ME | 1 |
Shah, SV | 1 |
3 review(s) available for ruboxistaurin and glucuronyl glucosamine glycan sulfate
Article | Year |
---|---|
The next generation of diabetic nephropathy therapies: an update.
Topics: Animals; Diabetic Nephropathies; Disease Progression; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Models, Animal; Protein Kinase C; Pyridoxamine; Renal Agents; Thiazoles | 2005 |
New potential agents in treating diabetic kidney disease: the fourth act.
Topics: Animals; Diabetic Nephropathies; Drugs, Investigational; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Renal Agents; Treatment Outcome | 2006 |
Progress toward novel treatments for chronic kidney disease.
Topics: Amides; Anticoagulants; Antihypertensive Agents; Bicarbonates; Chronic Disease; Enzyme Inhibitors; Fumarates; Glycosaminoglycans; Humans; Indoles; Iron Chelating Agents; Kidney Diseases; Kidney Failure, Chronic; Maleimides; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridones; Renin; Renin-Angiotensin System | 2010 |